BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10210108)

  • 1. Angiogenesis in endometrial cancer.
    Mazurek A; Telego M; Pierzyñski P; Lapuć G; Nikliñska W; Juczewska M; Chyczewski L
    Neoplasma; 1998; 45(6):360-4. PubMed ID: 10210108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.
    Mazurek A; Pierzynski P; Niklinska W; Chyczewski L; Laudanski T
    Neoplasma; 2002; 49(3):149-54. PubMed ID: 12097999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
    Mazurek A; Kuc P; Terlikowski S; Laudanski T
    Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
    Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
    Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer.
    Ribatti D; Finato N; Crivellato E; Marzullo A; Mangieri D; Nico B; Vacca A; Beltrami CA
    Am J Obstet Gynecol; 2005 Dec; 193(6):1961-5. PubMed ID: 16325597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
    Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers.
    Sato E; Fujimoto J; Tamaya T
    Oncology; 2007; 73(3-4):246-51. PubMed ID: 18424889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
    Giatromanolaki A; Sivridis E; Koukourakis MI; Georgoulias V; Gatter KC; Harris AL
    Oncol Res; 1999; 11(4):205-12. PubMed ID: 10566619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular proliferation is important for clinical progress of endometrial cancer.
    Stefansson IM; Salvesen HB; Akslen LA
    Cancer Res; 2006 Mar; 66(6):3303-9. PubMed ID: 16540684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
    Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histochemical evaluation of angiogenesis in endometrial adenocarcinoma.
    Puisoru M; Fatu C; Fatu IC
    Ann Anat; 2006 May; 188(3):255-9. PubMed ID: 16711164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
    Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
    Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and endometrial cancer.
    Sivridis E
    Anticancer Res; 2001; 21(6B):4383-8. PubMed ID: 11908694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
    Du XL; Jiang T; Sheng XG; Gao R; Li QS
    Gynecol Oncol; 2009 Dec; 115(3):371-6. PubMed ID: 19783287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
    Giavazzi R; Giuliani R; Coltrini D; Bani MR; Ferri C; Sennino B; Tosatti MP; Stoppacciaro A; Presta M
    Cancer Res; 2001 Jan; 61(1):309-17. PubMed ID: 11196179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage infiltration and angiogenesis in endometrial cancer.
    Hashimoto I; Kodama J; Seki N; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
    Anticancer Res; 2000; 20(6C):4853-6. PubMed ID: 11205231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
    Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
    Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
    Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.